Free Trial

The Clorox Company $CLX Stock Sold by Asset Management One Co. Ltd.

Clorox logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Asset Management One Co. cut its Clorox stake by 86.3% in the third quarter, selling 47,782 shares and ending the period with 7,598 shares worth about $616,000.
  • Clorox reported quarterly earnings of $1.55 per share, above the $1.07 consensus, and revenue of $1.91 billion, also exceeding estimates.
  • The company announced a quarterly dividend of $1.25 per share, equivalent to a 5.3% annualized yield. Its dividend payout ratio was reported at 103.73%, while analysts’ consensus rating was “Reduce.”
  • Five stocks to consider instead of Clorox.

Asset Management One Co. Ltd. lowered its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 86.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,598 shares of the company's stock after selling 47,782 shares during the quarter. Asset Management One Co. Ltd.'s holdings in Clorox were worth $616,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of CLX. Geneos Wealth Management Inc. grew its stake in Clorox by 9.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,402 shares of the company's stock valued at $145,000 after acquiring an additional 119 shares during the period. Elevation Wealth Partners LLC increased its holdings in Clorox by 32.3% in the 3rd quarter. Elevation Wealth Partners LLC now owns 565 shares of the company's stock worth $46,000 after acquiring an additional 138 shares in the last quarter. Root Financial Partners LLC raised its position in Clorox by 83.8% during the first quarter. Root Financial Partners LLC now owns 318 shares of the company's stock worth $33,000 after acquiring an additional 145 shares during the period. Eastern Bank raised its position in Clorox by 3.1% during the third quarter. Eastern Bank now owns 5,052 shares of the company's stock worth $409,000 after acquiring an additional 150 shares during the period. Finally, Mystic Asset Management Inc. lifted its holdings in Clorox by 1.3% during the third quarter. Mystic Asset Management Inc. now owns 12,112 shares of the company's stock valued at $981,000 after purchasing an additional 153 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Price Performance

Shares of NYSE CLX opened at $93.77 on Wednesday. The firm has a 50-day simple moving average of $88.00 and a 200-day simple moving average of $99.83. The stock has a market capitalization of $11.34 billion, a price-to-earnings ratio of 14.41, a price-to-earnings-growth ratio of 3.00 and a beta of 0.59. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80. The Clorox Company has a 52 week low of $79.12 and a 52 week high of $128.90.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Monday, November 2nd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.48. The firm had revenue of $1.91 billion for the quarter, compared to the consensus estimate of $1.88 billion. Clorox had a net margin of 9.41% and a return on equity of 601.88%. The company's revenue for the quarter was up 33.3% on a year-over-year basis. During the same period last year, the firm posted $0.85 earnings per share. On average, equities analysts predict that The Clorox Company will post 5.68 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Wednesday, October 28th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 5.3%. The ex-dividend date of this dividend is Wednesday, October 28th. Clorox's dividend payout ratio (DPR) is 103.73%.

Clorox News Roundup

Here are the key news stories impacting Clorox this week:

  • Positive Sentiment: Clorox reported adjusted EPS of $1.55, above the $1.07 consensus, and revenue of $1.91 billion versus estimates of $1.88 billion. Sales growth, cost savings and contributions from GOJO supported the quarter. Clorox shares rally after Q1 earnings beat
  • Positive Sentiment: The company gave fiscal 2027 adjusted EPS guidance of $5.70–$6.00 and revenue guidance of $7.6–$7.7 billion, broadly in line with or above analyst expectations. Productivity efforts, pricing and GOJO integration savings are intended to help offset cost pressure. Clorox Q1 earnings call highlights
  • Neutral Sentiment: Analyst price-target changes were mixed: UBS raised its target to $96 while maintaining a Neutral rating; TD Cowen lifted its target to $88, and JPMorgan raised its target to $86 but retained an Underweight rating. UBS target update
  • Negative Sentiment: Clorox expects adjusted earnings near the lower end of its outlook as inflation and other rising costs pressure margins, despite the quarterly beat. Its CEO also pointed to a potential warning sign in consumer spending, which could weigh on demand. Clorox trims outlook on higher costs Clorox CEO economic warning
  • Negative Sentiment: Investors may also be weighing debt from a recent acquisition and the potential implications for dividend flexibility. Clorox outlook and dividend concerns

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. TD Cowen reiterated a "hold" rating on shares of Clorox in a research report on Tuesday. Jefferies Financial Group cut shares of Clorox from a "buy" rating to a "hold" rating and cut their target price for the stock from $125.00 to $98.00 in a research note on Tuesday, July 28th. Evercore upgraded shares of Clorox from an "underperform" rating to a "hold" rating and set a $99.00 price target for the company in a research report on Monday. Barclays decreased their price target on shares of Clorox from $84.00 to $80.00 and set an "underweight" rating on the stock in a research note on Friday, October 16th. Finally, The Goldman Sachs Group reiterated a "sell" rating and issued a $74.00 price objective on shares of Clorox in a report on Tuesday. One investment analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have given a Sell rating to the company's stock. According to data from MarketBeat.com, Clorox currently has a consensus rating of "Reduce" and an average target price of $93.29.

View Our Latest Stock Analysis on CLX

Clorox Company Profile

(Free Report)

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt's Bees personal care items.

Featured Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines